Table 1. The relationship of UBE3C expression with 80 Patients’ clinical characteristics.
| Characteristic | Low UBE3C expression† (N = 47) | High UBE3C expression† (N = 33) | p value |
|---|---|---|---|
| Age | |||
| <50 y | 28 | 13 | |
| ≥50 y | 19 | 20 | 0.292 |
| Sex | |||
| Female | 22 | 17 | |
| Male | 25 | 16 | 0.427 |
| Tumor grade | |||
| I-II | 32 | 4 | |
| III-IV | 15 | 29 | 0.011* |
| Total resection | |||
| Party | 26 | 9 | |
| Total | 21 | 24 | 4.57E-5 |
| chemoradiotherapy | |||
| − | 19 | 5 | |
| + | 28 | 28 | 0.015 |
| GFAP | |||
| + | 21 | 7 | |
| − | 26 | 26 | 0.007 |
Abbreviations and Note: †, The staining intensity was graded as follows: Negative, 0-25% staining; Weakly, 26-50% staining; moderate, 51-75% staining; and strong, 76-100% staining = 4. UBE3Chigh, ≥51% of tumor section, and UBE3Clow, <51%; *Fisher’s Exact Test.